Potential immunogenicity of oncogene and tumor suppressor gene products
- 31 October 1993
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 5 (5) , 709-713
- https://doi.org/10.1016/0952-7915(93)90125-c
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53European Journal of Immunology, 1993
- Analysis of the Protective Effect of Different Sunscreens on Ultraviolet Radiation-Induced Local and Systemic Suppression of Contact Hypersensitivity and Inflammatory Responses in MiceJournal of Investigative Dermatology, 1993
- T cell clones specific for p21 ras‐derived peptides: Characterization of their fine specificity and HLA restrictionEuropean Journal of Immunology, 1993
- Molecular definition of tumor antigens recognized by T lymphocytesCurrent Opinion in Immunology, 1992
- Modifications of an immunodominant peptide antigen induce different anti‐polyoma tumor responses in two separate mouse strainsInternational Journal of Cancer, 1992
- p53, guardian of the genomeNature, 1992
- T-cell responses against products of oncogenes: Generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptidesHuman Immunology, 1992
- Tumor AntigensAnnual Review of Immunology, 1992
- Immunovirology of transforming virusesCurrent Opinion in Immunology, 1991